Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.87 -3.77%
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.4%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $37.4 million versus the consensus estimate of $38.28 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
- SailPoint Technologies Holdings (SAIL) Tops Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
